Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Methods × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Breast 1

Conditions

Breast Neoplasms 41 Colorectal Neoplasms 8 Breast Carcinoma In Situ 6 Uterine Cervical Neoplasms 5 Neoplasms 5 Lung Neoplasms 5 Prostatic Neoplasms 4 Colonic Neoplasms 4 Vulvar Neoplasms 3 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Lymphoma 3 Endometrial Neoplasms 3 Depression 3 Carcinoma, Intraductal, Noninfiltrating 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaginal Neoplasms 2 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Obesity 2 Motor Activity 2 Melanoma 2 Leukemia 2 Genital Neoplasms, Female 2 Fatigue 2 Weight Loss 1 Uterine Neoplasms 1 Thyroid Neoplasms 1

Interventions

Capecitabine 43 Paclitaxel 40 Trastuzumab 30 Fulvestrant 28 Cyclophosphamide 23 pembrolizumab 22 Carboplatin 22 Letrozole 18 Docetaxel 18 palbociclib 17 exemestane 17 Gemcitabine 17 Bevacizumab 15 eribulin 14 Lapatinib 12 Everolimus 12 Vinorelbine 11 Nivolumab 11 Anastrozole 11 trastuzumab deruxtecan 10 abemaciclib 10 Tamoxifen 10 Cisplatin 10 Albumin-Bound Paclitaxel 10 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Doxorubicin 9 Zoledronic Acid 8 Specimen Handling 8 olaparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02251353 2020-02-21

IMET

Federation of Breast Diseases Societies

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡